Inflammation is the key driver of liver fibrosis progression in non-alcoholic fatty liver disease (NAFLD). Unfortunately, it is often challenging to assess inflammation in NAFLD due to its dynamic nature and poor correlation with liver biochemical markers. Liver histology keeps its role as the standard tool, yet it is well-known for substantial sampling, intraobserver, and interobserver variability. Serum proinflammatory cytokines and apoptotic markers, namely cytokeratin-18, are well-studied with reasonable accuracy, whereas serum metabolomics and lipidomics have been adopted in some commercially available diagnostic models. Ultrasound and computed tomography imaging techniques are attractive due to their wide availability; yet their accuracies may not be comparable with magnetic resonance imaging-based tools. Machine learning and deep learning models, be they supervised or unsupervised learning, are promising tools to identify various subtypes of NAFLD, including those with dominating liver inflammation, contributing to sustainable care pathways for NAFLD.
Citations
Citations to this article as recorded by
Deep learning-based automated detection of endometrioid endometrial carcinoma in histopathology Ruotong Li, Kunyu Zou, Qihang Ma, Yaping Liu, Xiaohui Wang, Wenbin Huang, Shegan Gao, Xueying Yang Frontiers in Oncology.2026;[Epub] CrossRef
Diagnostic Performance of Shear-Wave Dispersion Slope for Biopsy-Proven Hepatic Inflammation in MASLD: A Systematic Review and HSROC Meta-Analysis Caixin Qiu, Meina Cai, Lulu Lyu, Peng Xu Ultrasound in Medicine & Biology.2026; 52(5): 916. CrossRef
ROS-Responsive Prodrug Containing Dihydroartemisinin and Cinnamaldehyde for the Potential Treatment of Nonalcoholic Steatohepatitis Ru Hao, Yi Sun, Changyuan Wang, Yang Wang, Lei Li, Huijun Sun, Lixue Chen ACS Applied Materials & Interfaces.2026; 18(9): 13384. CrossRef
Potential Drug Targets and Causal Plasma Proteins Related to Preeclampsia Identified by Mendelian Randomization Wei Zhou, Ting Huang, Lei Li, Yanli Shen, Zhe Ji, Meng Yan Women's Health Reports.2026;[Epub] CrossRef
Clinical Integration of Novel Non‐Invasive Biomarkers in Hepatology: Bridging Statistical Promise and Bedside Utility F. N. U. Mehrish, Talha Khan, Mujtaba Moazzam Journal of Gastroenterology and Hepatology.2026; 41(6): 1915. CrossRef
Chronic exposure to environmentally relevant Bisphenol F induces hepatic injury and inflammation in Zebrafish Yuehong Shen, Dingyu Zhou, Tong Wei, Tuantuan Lei, Yuanhui Zhu, Mengyuan Liang, Junjie Sun, Peng Wang, Guixiang Ji, Jie Gu, Han Gao, Wenzhu Wu Aquatic Toxicology.2026; 296: 107825. CrossRef
MAST versus FAST for active fibrotic MASH: a meta-analysis supporting risk-stratified diagnostic pathways Shengfang Liu, Qingjuan Zhang, Lijing Wang, Qin Tang, Bingtao Hu Frontiers in Medicine.2026;[Epub] CrossRef
Effects and Mechanisms of Stevioside on Metabolic Dysfunction‐Associated Steatotic Liver Disease Kangjun Li, Changfa Zhang, Lili Kang, Yunping Mu, Zemin Li, Jingyi Zhang, Guowei Li Food Science & Nutrition.2026;[Epub] CrossRef
Using machine learning to identify the most important predictors of fatty liver index in healthy young Taiwanese men Yu-Chen Tseng, Ta-Wei Chu, Chiu-Sung Ko, Dee Pei, Kai-Jo Chiang Scientific Reports.2026;[Epub] CrossRef
Imaging-based fibrosis assessment and risk stratification in MASLD Shunqin Jin, Tao Zhou, Dachuan Jin, Jiahao Xie, Guoping Sheng, Hongzhi Li, Guangming Li, Chuan Qin, Peng Gao Frontiers in Medicine.2026;[Epub] CrossRef
Mediation of the association between physical activity and metabolic dysfunction-associated fatty liver disease in children and adolescents by inflammatory markers: an analysis of 2017‒2020 NHANES data Chunyang Zhang, Xiaonan Li Clinics.2026; 81: 101056. CrossRef
Diagnosis of Portal Hypertension: Advancing Towards Non‐Invasive Solutions Lijia Yin, Huikuan Chu, Ling Yang Portal Hypertension & Cirrhosis.2026;[Epub] CrossRef
Automated Machine Learning Model for Non-Alcoholic Fatty Liver Disease Prediction and External Cohort Validation Mingjie Li, Yadong Li, Lihui Chen, Han Chen, Lishengdan Chen, Wenyue Liu, Gang Xu, Shuying Chen Journal of Visualized Experiments.2026;[Epub] CrossRef
Association between neutrophil-albumin ratio and ultrasound-defined metabolic dysfunction-associated fatty liver disease in U.S. adults: evidence from NHANES 2017–2018 Ming-yu He, Xin-jie Du, Yi-ming Liu BMC Gastroenterology.2025;[Epub] CrossRef
Validation of the diagnostic accuracy of the acFibroMASH index for at-risk MASH in patients with metabolic dysfunction-associated steatotic liver disease Yunfei Wu, Yan Han, Liming Zheng, Longgen Liu, Wenjian Li, Fan Zhang BMC Gastroenterology.2025;[Epub] CrossRef
Diagnostic Value of Serum Cytokeratin 18 for the Staging of Liver Inflammation and Fibrosis: A Meta‐Analysis Jinwen Chen, Jian Hu, Jialin Zhuang, Zhong Li, Se Peng, Xiaoting Huang, Jialing Zhuang Journal of Clinical Laboratory Analysis.2025;[Epub] CrossRef
Obesity: pathophysiology and therapeutic interventions Yue Kong, Haokun Yang, Rong Nie, Xuxiang Zhang, Fan Zuo, Hongtao Zhang, Xin Nian Molecular Biomedicine.2025;[Epub] CrossRef
The advanced lung cancer inflammation index has an L-shaped association with prognosis in American adults with metabolic dysfunction-associated fatty liver disease: a cohort study Yuexia Lu, Shuaipeng Yuan, Huazhao Xu, Jiqi Ouyang, Jinsheng Dong, Xin Jiang, Xiao Shao, Runshun Zhang Frontiers in Nutrition.2025;[Epub] CrossRef
Global Trends in Non-Invasive Techniques for the Diagnosis and Monitoring of Nonalcoholic Fatty Liver Disease: A Bibliometric and Visualization Analysis Jing-Wen Cai, Wei-Long Wang, Dong-Ling Lin, Shu-Feng Ren, Qian-Qian Jia, Xiao-Xuan He, Xue-Xia Yang, Wen Cai, Hui Hou Journal of Multidisciplinary Healthcare.2025; Volume 18: 4243. CrossRef
Gradual DNA methylation changes reveal transcription factors implicated in metabolic dysfunction-associated steatotic liver disease progression and epigenetic age acceleration Evelien Van Dijck, Steven Van Laere, Emilie Logie, Steven Timmermans, Erik Fransen, Joe Ibrahim, Timothy J. Kendall, Jonathan A. Fallowfield, Ligia M. Mateiu, Claude Libert, Guy Van Camp, An Verrijken, Luc Van Gaal, Sven Francque, Wim Van Hul, Wim Vanden Clinical Epigenetics.2025;[Epub] CrossRef
Quantification of 18F-FDG Delivery Rate for Liver Inflammation Using Shortened Dynamic PET Imaging Protocols Xiaoyu Duan, Souvik Sarkar, Victoria Lyo, Sean Romeo, Benjamin A. Spencer, Karen E. Matsukuma, Valentina Medici, Michael T. Corwin, Ramsey D. Badawi, Guobao Wang Journal of Nuclear Medicine.2025; 66(11): 1834. CrossRef
ChatGPT improves usability, effectiveness, scalability, interpretability and accessibility, in early diagnosis of metabolic dysfunction-associated fatty liver disease Xiaoying Zhou, Zhipeng Gao, Han Ma, Jiahui Hu, Chengfu Xu, Zhe Shen, Miaomiao Tan, Chaohui Yu BMC Gastroenterology.2025;[Epub] CrossRef
Low liver fat in non‐alcoholic steatohepatitis‐related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality Sung Won Lee, Daniel Q. Huang, Ricki Bettencourt, Veeral Ajmera, Monica Tincopa, Nabil Noureddin, Maral Amangurbanova, Harris Siddiqi, Egbert Madamba, Abdul M. Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Masato Yoneda, Ramzan I Alimentary Pharmacology & Therapeutics.2024; 59(1): 80. CrossRef
Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease Hye Kyung Hyun, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim, Jae Hee Cheon European Journal of Gastroenterology & Hepatology.2024; 36(4): 445. CrossRef
Evolutive Models, Algorithms and Predictive Parameters for the Progression of Hepatic Steatosis Marinela Sînziana Tudor, Veronica Gheorman, Georgiana-Mihaela Simeanu, Adrian Dobrinescu, Vlad Pădureanu, Venera Cristina Dinescu, Mircea-Cătălin Forțofoiu Metabolites.2024; 14(4): 198. CrossRef
Editorial: Inflammation and chronic disease Frank A. Orlando, Arch G. Mainous Frontiers in Medicine.2024;[Epub] CrossRef
Advances in Noninvasive Molecular Imaging Probes for Liver Fibrosis Diagnosis Shaofang Chen, Danping Zhuang, Qingyun Jia, Bing Guo, Genwen Hu Biomaterials Research.2024;[Epub] CrossRef
Serum Cytokeratin-18 levels as a prognostic biomarker in advanced liver disease: a comprehensive meta-analysis Xin Zhang, Jiangguo Li, Li Jiang, Yuexia Deng, Licheng Wei, Xing Li Clinical and Experimental Medicine.2024;[Epub] CrossRef
The Metabolomic Footprint of Liver Fibrosis Diren Beyoğlu, Yury V. Popov, Jeffrey R. Idle Cells.2024; 13(16): 1333. CrossRef
Machine learning based identification potential feature genes for prediction of drug efficacy in nonalcoholic steatohepatitis animal model Marwa Matboli, Ibrahim Abdelbaky, Abdelrahman Khaled, Radwa Khaled, Shaimaa Hamady, Laila M. Farid, Mariam B. Abouelkhair, Noha E. El-Attar, Mohamed Farag Fathallah, Manal S. Abd EL Hamid, Gena M. Elmakromy, Marwa Ali Lipids in Health and Disease.2024;[Epub] CrossRef
Structure-function analysis of time-resolved immunological phases in metabolic dysfunction-associated fatty liver disease (MASH) comparing the NIF mouse model to human MASH Anja Schmidt-Christensen, Gustaw Eriksson, William M. Laprade, Behnaz Pirzamanbein, Maria Hörnberg, Kajsa Linde, Julia Nilsson, Mark Skarsfeldt, Diana J. Leeming, Rajmund Mokso, Mariana Verezhak, Anders Dahl, Vedrana Dahl, Kristina Önnerhag, Massoud Rezae Scientific Reports.2024;[Epub] CrossRef
Polygala japonica Houtt.: A comprehensive review on its botany, traditional uses, phytochemistry, pharmacology, and pharmacokinetics Hai-Peng Tang, En-Lin Zhu, Qian-Xiang Bai, Shuang Wang, Zhi-Bin Wang, Meng Wang, Hai-Xue Kuang Fitoterapia.2024; 179: 106233. CrossRef
Chondroitin Sulfate from Halaelurus burgeri Skin Inhibits Hepatic Endoplasmic Reticulum Stress and Inflammation, and Regulates Gut Microbiota Zhaocai Ren, Shang Gao, Shiwei Hu, Sichun Chen, Wei Jiang, Yaming Ge Molecular Nutrition & Food Research.2024;[Epub] CrossRef
Serum Cytokeratin 18 Fragment Is an Indicator for Treating Metabolic Dysfunction-Associated Steatotic Liver Disease Miwa Kawanaka, Yoshihiro Kamada, Hirokazu Takahashi, Michihiro Iwaki, Ken Nishino, Wenli Zhao, Yuya Seko, Masato Yoneda, Yoshihito Kubotsu, Hideki Fujii, Yoshio Sumida, Hirofumi Kawamoto, Yoshito Itoh, Atsushi Nakajima, Takeshi Okanoue, Takumi Kawaguchi, Gastro Hep Advances.2024; 3(8): 1120. CrossRef
Metabolomic Hallmarks of Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease Diren Beyoğlu, Yury V. Popov, Jeffrey R. Idle International Journal of Molecular Sciences.2024; 25(23): 12809. CrossRef
MASLD: predictive value for liver-related events and extra-hepatic complications Mohamad Jamalinia, Amedeo Lonardo Expert Review of Gastroenterology & Hepatology.2024; 18(11): 685. CrossRef
Baseline Tyrosine Level Is Associated with Dynamic Changes in FAST Score in NAFLD Patients under Lifestyle Modification Hwi Young Kim, Da Jung Kim, Hye Ah Lee, Joo-Youn Cho, Won Kim Metabolites.2023; 13(3): 444. CrossRef
Prospective direct comparison of non‐invasive liver tests in outpatients with type 2 diabetes using intention‐to‐diagnose analysis Thierry Poynard, Olivier Deckmyn, Valentina Peta, Valérie Paradis, Jean‐Francois Gautier, Angélique Brzustowski, Pierre Bedossa, Laurent Castera, Stanislas Pol, Dominique Valla Alimentary Pharmacology & Therapeutics.2023; 58(9): 888. CrossRef